Markers of hypercoagulability in cancer patients

Haemostasis
P M Mannucci

Abstract

In the last few years, several assays have been developed that permit the evaluation, with a high degree of sensitivity, of the level of activation of the coagulation system. Some of these tests have been used in cancer patients, in an attempt to monitor the risks of tumour progression and the development of thromboembolic complications. Even though coagulation activation markers are often abnormally elevated, the results available so far do not indicate that they are useful in the clinical management of individual cancer patients.

Citations

Jan 31, 2002·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·P Di MiccoR Torella
Apr 13, 2000·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·N VilaA Chamorro
Mar 3, 2001·American Journal of Obstetrics and Gynecology·T BombeliJ Fehr

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.